Salk Institute researchers, in collaboration with the National Institutes of Health, have discovered the molecular mechanisms by which the human immunodeficiency virus (HIV) becomes resistant to Dolutegravir, one of the most effective, clinically used antiviral drugs for treating HIV.
American Bar Association says lower court was ‘ill-equipped’ to restrict abortion pill use
The American Bar Association joined the choir of industry groups, former FDA officials, members of Congress and others asking the Supreme Court to keep revisions
February 6, 2024